A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
Clinical trial NCT04637828 · UNKNOWN
Trial details
- NCT number
- NCT04637828
- Sponsor
- Genoscience Pharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2021-07-30
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.